Pathologically-proven intracranial germinoma treated with radiation therapy.
OBJECTIVE
A retrospective multi-institutional study was conducted to survey what percentage of intracranial germinomas were treated with pathological confirmation before radiotherapy and to investigate the influence of field selection on outcome.


METHODS
Thirty-seven percent of patients (41 of 110 patients) were pathologically confirmed before radiotherapy during the past 16 years at eight institutions in Northern Japanese prefectures. Pathological confirmation was obtained in 26, 37 and 53% of cases during 1978-1983, 1984-1989 and 1990-1994, respectively. All 110 patients were examined using computed tomography (CT) scans. Among the 41 patients with pathologically confirmed germinoma, radiation fields were craniospinal in 23 patients, whole-brain in 10 patients and local without ventricle inclusion in eight patients.


RESULTS
For the 41 patients with pathologically confirmed germinoma, the actuarial and cause-specific survival rates were 91/94% at 5 years and 87/90% at 10 years, respectively. The relapse-free survival rate at 10 years was 90. 76 and 22% for the craniospinal field, whole-brain field and local field without ventricle inclusion, respectively.


CONCLUSIONS
Pathological confirmation was obtained in only 37% of CT-scan era cases, although the confirmations were more commonly carried out later in the study period. Limited local irradiation alone without ventricle inclusion cannot be recommended for localized tumors even with the help of CT scanning.
Aoyama
H
H
Department of Radiology, Hokkaido University School of Medicine, Sapporo, Japan.
Shirato
H
H
Kakuto
Y
Y
Inakoshi
H
H
Nishio
M
M
Yoshida
H
H
Hareyama
M
M
Yanagisawa
T
T
Watarai
J
J
Miyasaka
K
K
D000293:Adolescent; D000328:Adult; D001706:Biopsy; D001932:Brain Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000532:radiotherapy*; D002648:Child; D005260:Female; D018237:Germinoma / Q000175:diagnosis / Q000401:mortality / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D012189:Retrospective Studies; D015996:Survival Rate